A Study on Efficacy and Safety of Menopur® Multidose in Korean Female Patients With Infertility

Inclusion Criteria: * Decision made to prescribe Menopur® multidose according to Summary of product characteristics * The study cycle will be either * 1st controlled ovarian stimulation cycle ever, or * 2nd controlled ovarian stimulation cycle ever, or * 1st or 2nd controlled ovarian stimulation cycle after having achieved ongoing pregnancy in a previous controlled ovarian stimulation cycle (note: the subject cannot be included if she has had made more than one failed cycle before the cycle resulting in ongoing pregnancy) Exclusion Criteria: * Known ovarian disease (e.g. ovarian cysts, polycystic ovarian disease etc.) * Diagnosed as "poor responder", defined as either * \>20 days of gonadotrophin stimulation in a previous controlled ovarian stimulation cycle, or * any previous cancellation of a controlled ovarian stimulation cycle due to limited follicular response, or * development of less than 4 follicles ≥15 mm in a previous controlled ovarian stimulation cycle * Ovarian hyperstimulation syndrome (OHSS)